About Papaya (Carica papaya) Fruit Powder
Papaya fruit powder appears at milligram levels in multivitamins and digestive blends, trading on the fruit's papain enzyme content — but the enzyme itself is covered by the separate papain entry, and fruit powder at 5–10 mg carries negligible enzyme activity. Human evidence for the fruit as a supplement is limited to fermented papaya preparation (FPP, Immun'Âge) at 6–9 g/day: small trials report changes in oxidative-stress markers in type 2 diabetes and older adults, without consistent clinical outcomes; Dickerson 2012 (type 2 diabetes, 9 g/day FPP) showed correction of NADPH-oxidase activity in blood cells; Bertuccelli 2016 reported skin-ageing marker changes vs an antioxidant control. Papaya leaf extract has separate RCT data for platelet counts in dengue (not applicable to fruit powder). Safe as food; ripe fruit is well tolerated. Unripe papaya/latex is traditionally avoided in pregnancy.
What Papaya (Carica papaya) Fruit Powder supports
- Fermented papaya (6–9 g/day) shifts oxidative-stress markers in small trials
How much Papaya (Carica papaya) Fruit Powder to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
1000–9000
mg
No clinical dose exists for papaya fruit powder. The only controlled human data are for fermented papaya preparation (FPP) at 6–9 g/day (small trials on oxidative-stress markers in diabetes/elderly, mixed). Multivitamin garnish doses of 5–10 mg are cosmetic and contribute nothing measurable; papaya leaf extract (dengue platelet trials) is a different plant part and not covered here.
Clinical evidence
Clinical evidence. No RCTs of papaya fruit powder; only small fermented-papaya trials at gram doses with biomarker endpoints — milligram multivitamin doses are cosmetic
NIH Fact Sheet